This ratio is outperformed by other biomarkers (such as neurofilament light chain (NfL) or phospho-tau 217 (pTau217) for discriminating between cognitive impairment due to AD and other causes of dementia [8]. This evidence concerns the gene NEFL and Alzheimer disease.